Viatris names Corinne Le Goff as Chief Commercial Officer Ruchika Sharma16 April 2024 12:30 PM ISTPittsburgh: Viatris Inc., a global healthcare company, has announced that Corinne Le Goff has joined the company as Chief Commercial Officer...
USFDA declines to approve Viatris-Mapi Pharma's monthly multiple sclerosis injection Ruchika Sharma12 March 2024 11:56 AM ISTThe companies were seeking the FDA's nod for GA Depot, a long-acting version of glatiramer acetate, which is approved for relapsing forms of MS.
Viatris Aurangabad facility gets Global Minimized Risk of Antimicrobial Resistance Certification Ruchika Sharma21 Feb 2024 1:30 PM ISTIndia: Viatris Inc., a global healthcare company, has announced that its Aurangabad, India, facility has received certification from the...
Rajiv Malik to retire as President of Viatris effective April 1, 2024 Ruchika Sharma23 Oct 2023 11:15 AM ISTPittsburgh: Viatris Inc., a global healthcare company, has announced that its President, Rajiv Malik, will be retiring as an executive of the...
Viatris to divest India API, women's healthcare businesses for USD 1.2 billion Roshni Dhar5 Oct 2023 3:52 PM ISTViatris (formerly known as Mylan Inc) has finalised two deals in India to divest its API (active pharmaceutical ingredients) and women's healthcare...
Health Bulletin 04/October/2023 Roshni Dhar4 Oct 2023 4:27 PM ISTHere are the top health stories for the day:PG Medical admissions: Is zero percentile compromising merit?Experts have expressed their concern as...
Viatris, Ocuphire Pharma get USFDA nod for Ryzumvi for treatment of Pharmacologically-Induced Mydriasis Ruchika Sharma2 Oct 2023 11:30 AM ISTPittsburgh: Viatris Inc., a global healthcare company, and Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on...
Viatris gets USFDA tentative nod for paediatric formulation of Abacavir, Dolutegravir, Lamivudine for children with HIV Ruchika Sharma5 Sept 2023 3:54 PM ISTBangalore: Viatris Inc., a global healthcare company, today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug...
Viatris closes acquisitions of Famy Life Sciences, Oyster Point Pharma to establish eye care division Ruchika Sharma4 Jan 2023 1:15 PM ISTThe aggregate acquisition price for the Famy Life Sciences business is expected to be approximately $280 million.
Biocon Biologics, Viatris launch cancer medicine Abevmy in Canada Ruchika Sharma20 May 2022 3:02 PM ISTAbevmy is a recombinant humanized monoclonal antibody that selectively binds to human vascular endothelial growth factor (VEGF) and neutralizes its...
